Background
Discrimination and stigmatization of patients who use psychoactive drugs or who have addiction is common in health care.1–4 Using people-first, medically accurate, and stereotype-reducing language with colleagues, trainees, and in documentation5 is fundamental to dispelling stigma6 and misperceptions, such as the myth of addiction as a willful personal choice or moral failing. The right words can convey empathy and reduce mistrust in health care for patients who have often faced a history of marginalization. This Fast Facts discusses health care stigmatization of patients who use drugs or have addiction, and will present preferred language that respects personhood, supports recovery, promotes accurate knowledge about the full spectrum of substance use, and supports an understanding of addiction as a chronic treatable condition (see Fast Fact #127).
Stigma in Health Care
Stigma is a social process that occurs in the context of power,7 characterized by labeling, stereotyping, and discrimination based on real or perceived attributes. Stigma toward people who use drugs or develop addiction, as well as medications to treat this condition, are long-standing. Opioid use disorder (OUD) has long been treated apart from mainstream medicine in the United States, from the 1914 Harrison Narcotics Act that separated treatment of OUD away from routine health care,8 to the racist “War on Drugs” that treated drug use as a criminal-legal issue removed from public health. Clinicians themselves commonly have negative biases about addiction,9–11 which is often reinforced during medical training through stigmatizing language.12 For example, patients described as “substance abusers” were perceived by clinicians as more threatening, more worthy of blame, and less likely to benefit from treatment compared with “persons with an SUD.”13 Altogether, stigma worsens the mental and physical health of people who use drugs,14–16 disproportionately affects communities of color,17 and harms patients on long-term therapeutic opioids.18,19 It even underlies the crisis of overdose deaths, as only 12.5% of people with OUD receive medication proven to reduce accidental overdose.18,19 The following table presents preferred language for clinicians:
| Preferred language20,21 | Nonpreferred language |
|---|---|
| Substance use disorder (SUD), opiod use disorder (OUD), alcohol use disorder, unhealthy/risky use (preferred to misuse), nonmedical use, addiction (which can be used to mean severe SUD per the DSM 5) | Substance/drug/alcohol abuse, drug/drinking problem. The terms dependence and addiction may be used by patients; however, dependence clinically refers to physiological withdrawal reactions when a substance is stopped. It may occur without a SUD and should not be used synonymously by clinicians with SUD/addiction. |
| Addiction is a chronic condition characterized by the compulsive use of a substance despite harmful consequences. | Using language such as choice, lifestyle, moral failing, lack of will power, or personal failure to describe SUD/addiction |
| Person with a SUD, person with addiction, person who uses drugs, person who injects drugs (PWID) | Addict, drug/substance abuser, person with a drug habit, alcoholic, IV drug user, drug-seeker |
| Person not actively using, person in remission from SUD, person in recovery | Clean, former addict. The term sober is generally not used by clinicians, although some patients use it themselves. |
| Substance present/not present in urine screen | Dirty/clean urine. Describing urine as positive or negative for a substance can be clinically confusing. |
| Medications for OUD (MOUD), Medication for addiction treatment (MAT), Opioid agonist therapy (OAT) | Opioid replacement therapy and opioid substitution are not preferred as they stigmatize MOUD as “replacing one addiction with another.” Medication-assisted treatment is not preferred because MOUD alone can save lives without additional treatment for some patients. |
| Patient-directed discharge, patient left before treatment completion despite medical recommendations, patient declined further treatment after informed consent | Leaving against medical advice, AMA, eloped: these clinical designations have no clinical, regulatory, or professional standards. As such they can stigmatize patients, worsen health outcomes, and disproportionately affect vulnerable populations.22 |
|
Undertreated pain, risky opioid use (e.g., self-titration of meds, etc.) related to undertreated pain (instead of pseudoaddiction) Using opioids to treat nonpain symptoms (instead of chemical coping) |
Pseudoaddiction, chemical coping: these nondiagnostic euphemisms are applied inconsistently and subject to unconscious bias by, for example, clinicians to describe patients with OUD, for whom the clinician does not feel comfortable “labeling” as having OUD. This stigmatizes OUD and can prevent appropriate treatment.23 |
| Opioids | Narcotics (which is used in a legal context to refer to multiple classes of illegal substances not just opioids) |
Summary
The language used to describe substance use and addiction must convey respect for individuals, an accurate understanding of the full spectrum of substance use (from nonproblematic use to chaotic use and addiction), and effective treatment. Avoid perpetuating negative stereotypes by first recognizing, addressing, and combatting misunderstandings and stigma.
References
- 1. Volkow ND: Stigma and the toll of addiction. N Engl J Med 2020;382:1289–1290. [DOI] [PubMed] [Google Scholar]
- 2. Woods JS, Joseph H: Stigma from the viewpoint of the patient. J Addict Dis 2015;34:238–247. [DOI] [PubMed] [Google Scholar]
- 3. Ebenau A, Dijkstra B, ter Huurne C, et al. : Palliative care for patients with substance use disorder and multiple problems: A qualitative study on experiences of healthcare professionals, volunteers and experts-by-experience. BMC Palliat Care 2020;19:8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. McCradden MD, Vasileva D, Orchanian-Cheff A, Buchman DZ: Ambiguous identities of drugs and people: A scoping review of opioid-related stigma. Int J Drug Policy 2019;74:205–215. [DOI] [PubMed] [Google Scholar]
- 5. P. Goddu A, O'Conor KJ, Lanzkron S, et al.: Do words matter? Stigmatizing language and the transmission of bias in the medical record. J Gen Intern Med 2018;33:685–691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Wakeman SE: Language and addiction: Choosing words wisely. Am J Public Health 2013;103:e1–e2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Link BG, Phelan JC: Conceptualizing stigma. Annu Rev Sociol 2001;27:363–385. [Google Scholar]
- 8. Courtwright DT: Preventing and treating narcotic addiction—Century of Federal Drug Control. N Engl J Med 2015;373:2095–2097. [DOI] [PubMed] [Google Scholar]
- 9. Adams VJM, Volkow ND: Ethical imperatives to overcome stigma against people with substance use disorders. AMA J Ethics 2020;22:702–708. [DOI] [PubMed] [Google Scholar]
- 10. van Boekel LC, Brouwers EPM, van Weeghel J, Garretsen HFL: Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: Systematic review. Drug Alcohol Depend 2013;131:23–35. [DOI] [PubMed] [Google Scholar]
- 11. Atkins J, Dopp AL, Temaner EB: Combatting the stigma of addiction—The need for a Comprehensive Health System Approach. NAM Perspectives [Internet]. November 9, 2020 [cited February 18, 2021]. https://nam.edu/combatting-the-stigma-of-addiction-the-need-for-a-comprehensive-health-system-approach/ (Last accessed February 18, 2021). [DOI] [PMC free article] [PubMed]
- 12. Avery J, Knoepflmacher D, Mauer E, et al. : Improvement in residents' attitudes toward individuals with substance use disorders following an online training module on stigma. HSS J 2019;15:31–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Kelly JF, Dow SJ, Westerhoff C: Does our choice of substance-related terms influence perceptions of treatment need? An empirical investigation with two commonly used terms. J Drug Issues 2010;40:805–818. [Google Scholar]
- 14. Bearnot B, Mitton JA, Hayden M, Park ER: Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study. J Subst Abuse Treat 2019;102:16–22. [DOI] [PubMed] [Google Scholar]
- 15. Simon R, Snow R, Wakeman S: Understanding why patients with substance use disorders leave the hospital against medical advice: A qualitative study. Subst Abus 2020;41:519–525. [DOI] [PubMed] [Google Scholar]
- 16. Wakeman SE, Rich JD: Barriers to medications for addiction treatment: How stigma kills. Subst Use Misuse 2018;53:330–333. [DOI] [PubMed] [Google Scholar]
- 17. Race and the Drug War: Drug policy alliance [Internet]. [cited March 8, 2021]. https://drugpolicy.org/issues/race-and-drug-war (Last accessed March 8, 2021).
- 18. Wakeman SE, Larochelle MR, Ameli O, et al. : Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open 2020;3:e1920622–e1920622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Tsai AC, Kiang MV, Barnett ML, et al. : Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLOS Med 2019;16:e1002969. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Kelly JF, Wakeman SE, Saitz R: Stop Talking ‘Dirty’: Clinicians, language, and quality of care for the leading cause of preventable death in the United States. Am J Med 2015;128:8–9. [DOI] [PubMed] [Google Scholar]
- 21. Botticelli MP, Koh HK: Changing the language of addiction. JAMA 2016;316:1361–1362. [DOI] [PubMed] [Google Scholar]
- 22. Alfandre D, Brenner J, Onukwugha E: Things we do for no reason: Against medical advice discharges. J Hosp Med 2017;12:843–845. [DOI] [PubMed] [Google Scholar]
- 23. Bell K, Salmon A: Pain, physical dependence and pseudoaddiction: Redefining addiction for ‘nice’ people? Int J Drug Policy 2009;20:170–178. [DOI] [PubMed] [Google Scholar]
